Fingeraftryk
Dyk ned i forskningsemnerne om 'Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial'. Sammen danner de et unikt fingeraftryk.- Sorter
- Vægt
- Alfabetisk
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
Catherine Thieblemont*, Yasmin H. Karimi, Herve Ghesquieres, Chan Y. Cheah, Michael Roost Clausen, David Cunningham, Wojciech Jurczak, Young Rok Do, Robin Gasiorowski, David John Lewis, Tae Min Kim, Marjolein van der Poel, Michelle Limei Poon, Tatyana Feldman, Kim M. Linton, Anna Sureda, Martin Hutchings, Minh H. Dinh, Nurgul Kilavuz, David Soong
*Kontaktforfatter
- Paris Descartes University
- University of Michigan
- Lyon Sud Hospital Center
- Sir Charles Gairdner Hospital
- The Royal Marsden NHS Foundation Trust
- MSC National Research Institute of Oncology
- Keimyung University Dongsan Medical Center
- The University of Sydney
- Derriford Hospital
- Seoul National University Hospital
- Maastricht University
- National University of Singapore
- Hackensack Meridian School of Medicine
- The University of Manchester
- University of Barcelona
- Københavns Universitet
- AbbVie Inc.
- Genmab US
- Genmab A/S
- University of Michigan Comprehensive Cancer Center
- Erasmus University Medical Center Rotterdam
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review